Stockscreener 앱 받기
88.41
2.17%
-2.0524
전일 마감가:
$90.46
열려 있는:
$89.16
하루 거래량:
494.61K
Relative Volume:
0.37
시가총액:
$11.96B
수익:
$2.51B
순이익/손실:
$185.56M
주가수익비율:
65.98
EPS:
1.34
순현금흐름:
$517.59M
1주 성능:
-8.49%
1개월 성능:
+1.14%
6개월 성능:
+46.04%
1년 성능:
+12.28%
1일 변동 폭
$88.20
$90.88
1주일 범위
$88.20
$96.00
52주 변동 폭
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
명칭
Globus Medical Inc
전화
610-930-1800
주소
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
88.41 | 12.23B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
110.98 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.85 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
92.72 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.91 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.59 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | Needham | Hold → Buy |
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2025-11-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-11-07 | 업그레이드 | Truist | Hold → Buy |
| 2025-10-28 | 재개 | Stifel | Hold |
| 2025-05-27 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-01-10 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-19 | 업그레이드 | Stifel | Hold → Buy |
| 2023-03-30 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-02-10 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Needham | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Truist | Buy → Hold |
| 2023-02-10 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-28 | 개시 | Wells Fargo | Overweight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-10-29 | 개시 | Loop Capital | Buy |
| 2021-02-18 | 재개 | Needham | Buy |
| 2020-12-08 | 개시 | Citigroup | Buy |
| 2020-10-20 | 개시 | Stifel | Hold |
| 2020-08-06 | 재확인 | Needham | Buy |
| 2020-08-06 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 개시 | Northland Capital | Market Perform |
| 2020-07-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 재확인 | Needham | Buy |
| 2020-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-12 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 재확인 | Needham | Buy |
| 2019-05-24 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 재확인 | Needham | Buy |
| 2019-02-28 | 업그레이드 | UBS | Neutral → Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-27 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 재확인 | Needham | Buy |
| 2018-04-04 | 업그레이드 | Needham | Hold → Buy |
모두보기
Globus Medical Inc 주식(GMED)의 최신 뉴스
Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges - Yahoo Finance
Globus Medical (NYSE:GMED) Stock Rating Upgraded by Zacks Research - MarketBeat
Is This the Right Time to Add Globus Medical Stock to Your Portfolio? - TradingView
Assessing Globus Medical (GMED) Valuation After Recent Share Price Pullback And Mixed Fair Value Signals - simplywall.st
GW&K Investment Management LLC Sells 72,271 Shares of Globus Medical, Inc. $GMED - MarketBeat
Burgundy Asset Management Ltd. Has $212.05 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Globus Medical: Is the Post-Deal Integration Machine Turning NuVasive and Nevro Into a Real Musculoskeletal Powerhouse? - Smartkarma
Globus Medical Reports Fourth-Quarter and Full-Year 2025 Results - MyChesCo
Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
Segall Bryant & Hamill LLC Buys 13,583 Shares of Globus Medical, Inc. $GMED - MarketBeat
Champlain Investment Partners LLC Acquires 365,418 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical, Inc. (GMED) Stock Analysis: A Healthcare Innovator with 14.75% Upside Potential - DirectorsTalk Interviews
Globus Medical, Inc. $GMED Shares Purchased by William Blair Investment Management LLC - MarketBeat
DNB Asset Management AS Buys 67,911 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Stock After NuVasive Deal: Breakout Setup or Value Trap for US Investors? - AD HOC NEWS
Globus Medical (GMED) Is Up 5.4% After Record 2025 Earnings and Raised EPS Outlook Has The Bull Case Changed? - Sahm
Globus Medical (NYSE:GMED) EVP Sells $1,890,000.00 in Stock - MarketBeat
Globus Medical Executive Sells 20,000 Shares - TradingView
Globus Medical Insider Sold Shares Worth $1,890,000, According to a Recent SEC Filing - marketscreener.com
Globus Medical (GMED) EVP executes options, sells 20,000 shares under 10b5-1 plan - Stock Titan
Globus Medical Record Q4 And Synergies Refocus Valuation And Growth Debate - Yahoo Finance
Globus Medical (NYSE:GMED) Updates FY 2026 Earnings Guidance - MarketBeat
Wells Fargo Raises Price Target for GMED to $104 | GMED Stock Ne - GuruFocus
Wells Fargo & Company Raises Globus Medical (NYSE:GMED) Price Target to $104.00 - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Q4 2025 Earnings Call Transcript - Insider Monkey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Globus Medical (GMED) Net Margin Reset Tests Bullish Long Term Earnings Narratives - Sahm
Truist raises Globus Medical stock price target on synergy gains - Investing.com South Africa
Globus Medical Earnings Call Shows Profitable Growth - TipRanks
GMED (GMED) Form 144: 20,000-share cashless option sale reported - Stock Titan
Globus Medical: Strengthening U.S. Spine Momentum and Innovation-Driven Double-Digit Growth Supports Buy Rating and Upside Valuation - TipRanks
Enovis (ENOV) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance UK
Truist raises Globus Medical stock price target on synergy gains By Investing.com - Investing.com Canada
GMED Analyst Rating Update: Barclays Raises Price Target to $123 - GuruFocus
Globus Medical Reports Fourth Quarter and Full Year 2025 Results - Ortho Spine News
Barclays Issues Positive Forecast for Globus Medical (NYSE:GMED) Stock Price - MarketBeat
TD Cowen raises Globus Medical stock price target on spine momentum - Investing.com Canada
Jefferies raises Globus Medical stock price target on strong quarter By Investing.com - Investing.com Nigeria
Needham raises Globus Medical stock price target on earnings beat By Investing.com - Investing.com South Africa
Needham raises Globus Medical stock price target on earnings beat - Investing.com Nigeria
Needham Raises Price Target on Globus Medical to $114 From $112, Keeps Buy Rating - marketscreener.com
Truist Raises Price Target on Globus Medical to $115 From $105, Keeps Buy Rating - marketscreener.com
Globus Medical (NYSE:GMED) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Globus Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Vanguard Group Inc. Sells 103,146 Shares of Globus Medical, Inc. $GMED - MarketBeat
Jefferies raises Globus Medical stock price target on strong quarter - Investing.com India
8 Analysts Assess Globus Medical: What You Need To Know - Benzinga
Globus Medical sales up 25.7% to USD 826.4M in Q4 2025 - Medical Buyer
GMED: Needham Maintains Buy Rating and Raises Price Target | GME - GuruFocus
Is It Too Late To Consider Globus Medical (GMED) After Recent Share Price Strength? - Sahm
Research Alert: CFRA Retains Hold Opinion On Shares Of Globus Medical Inc. - 富途牛牛
Globus Medical Inc (GMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.20%
자본화:
|
볼륨(24시간):